Acquisitions - Summary of Consideration Transferred (Details) - USD ($) $ in Thousands |
Feb. 21, 2025 |
Jan. 23, 2025 |
---|---|---|
Molecular | ||
Business Combination [Line Items] | ||
Cash paid | $ 9,212 | |
Consideration payable | 2,000 | |
Total consideration transferred | $ 11,212 | |
Officinae Bio | ||
Business Combination [Line Items] | ||
Cash paid | $ 9,930 | |
Fair value of contingent consideration | 4,800 | |
Consideration payable | 331 | |
Total consideration transferred | $ 15,061 |
X | ||||||||||
- Definition Business Combination, Consideration Payable No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|